A Call to Arms: Quest for a Cryptococcal Vaccine

Overview

Journal Trends Microbiol

Date 2017 Nov 7

PMID 29103990

Citations 36

Authors

Marley C Caballero Van Dyke

Floyd L Wormley Jr

Affiliations

Soon will be listed here.

Abstract

Cryptococcosis remains a significant cause of morbidity and mortality world-wide, particularly among AIDS patients. Yet, to date, there are no licensed vaccines clinically available to treat or prevent cryptococcosis. In this review, we provide a rationale to support continued investment in Cryptococcus vaccine research, potential challenges that must be overcome along the way, and a literature review of the current progress underway towards developing a vaccine to prevent cryptococcosis.

Citing Articles

infections: aspartyl protease potential to improve outcome in susceptible hosts.

Vernel-Pauillac F, Laurent-Winter C, Fiette L, Janbon G, Aimanianda V, Dromer F mBio. 2024; 15(11):e0273324.

PMID: 39440979 PMC: 11559057. DOI: 10.1128/mbio.02733-24.

Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections.

Kulkarni N, Nanjappa S Vaccines (Basel). 2024; 12(9).

PMID: 39340013 PMC: 11435842. DOI: 10.3390/vaccines12090981.

Inhibition of host 5-lipoxygenase reduces overexuberant inflammatory responses and mortality associated with meningoencephalitis.

Castro-Lopez N, Campuzano A, Mdalel E, Vanegas D, Chaturvedi A, Nguyen P mBio. 2024; 15(9):e0148324.

PMID: 39082787 PMC: 11389364. DOI: 10.1128/mbio.01483-24.

Adjuvant ArtinM favored the host immunity against infection in C57BL/6 mice.

Martins Oliveira-Brito P, de Campos G, Guimaraes J, Machado M, Serafim L, Lazo Chica J Immunotherapy. 2024; 16(11):733-748.

PMID: 38940276 PMC: 11421300. DOI: 10.1080/1750743X.2024.2360384.

Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi.

Wang Z, Shao J Arch Microbiol. 2024; 206(7):293.

PMID: 38850421 DOI: 10.1007/s00203-024-04010-7.

References

Yanagisawa K, Exley M, Jiang X, Ohkochi N, Taniguchi M, Seino K . Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide. Cancer Res. 2006; 66(23):11441-6. DOI: 10.1158/0008-5472.CAN-06-0944. View

Murphy J, Mosley R, CHERNIAK R, Reyes G, Kozel T, Reiss E . Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun. 1988; 56(2):424-31. PMC: 259299. DOI: 10.1128/iai.56.2.424-431.1988. View

Chang C, Crane M, Zhou J, Mina M, Post J, Cameron B . HIV and co-infections. Immunol Rev. 2013; 254(1):114-42. PMC: 3697435. DOI: 10.1111/imr.12063. View

Walraven C, Gerstein W, Hardison S, Wormley F, Lockhart S, Harris J . Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One. 2011; 6(12):e28625. PMC: 3237461. DOI: 10.1371/journal.pone.0028625. View

Shoham S, Marr K . Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012; 7(5):639-55. PMC: 4222063. DOI: 10.2217/fmb.12.28. View

Cowen L . Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathog. 2009; 5(8):e1000471. PMC: 2726949. DOI: 10.1371/journal.ppat.1000471. View

Rachini A, Pietrella D, Lupo P, Torosantucci A, Chiani P, Bromuro C . An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun. 2007; 75(11):5085-94. PMC: 2168274. DOI: 10.1128/IAI.00278-07. View

Liu T, Perlin D, Xue C . Molecular mechanisms of cryptococcal meningitis. Virulence. 2012; 3(2):173-81. PMC: 3396696. DOI: 10.4161/viru.18685. View

Chau T, Mai N, Phu N, Nghia H, Chuong L, Sinh D . A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis. 2010; 10:199. PMC: 2910700. DOI: 10.1186/1471-2334-10-199. View

10.

Hu X, Wu J, Zhu L, Wang X, Xu B, Wang R . Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients. PLoS One. 2012; 7(8):e42439. PMC: 3411792. DOI: 10.1371/journal.pone.0042439. View

11.

Singh N, Lortholary O, Alexander B, Gupta K, John G, Pursell K . An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis. 2005; 40(12):1756-61. DOI: 10.1086/430606. View

12.

Pietrella D, Corbucci C, Perito S, Bistoni G, Vecchiarelli A . Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation. Infect Immun. 2005; 73(2):820-7. PMC: 547028. DOI: 10.1128/IAI.73.2.820-827.2005. View

13.

Quintin J, Saeed S, Martens J, Giamarellos-Bourboulis E, Ifrim D, Logie C . Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe. 2012; 12(2):223-32. PMC: 3864037. DOI: 10.1016/j.chom.2012.06.006. View

14.

Fleuridor R, Lees A, Pirofski L . A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol. 2001; 166(2):1087-96. DOI: 10.4049/jimmunol.166.2.1087. View

15.

Kakeya H, Udono H, Maesaki S, Sasaki E, Kawamura S, Hossain M . Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis. Clin Exp Immunol. 1999; 115(3):485-90. PMC: 1905239. DOI: 10.1046/j.1365-2249.1999.00821.x. View

16.

Rodrigues M, Shi L, Barreto-Bergter E, Nimrichter L, Farias S, Rodrigues E . Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection. Clin Vaccine Immunol. 2007; 14(10):1372-6. PMC: 2168121. DOI: 10.1128/CVI.00202-07. View

17.

van der Horst C, Saag M, Cloud G, Hamill R, Graybill J, Sobel J . Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997; 337(1):15-21. DOI: 10.1056/NEJM199707033370103. View

18.

Chen J, Varma A, Diaz M, Litvintseva A, Wollenberg K, Kwon-Chung K . Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis. 2008; 14(5):755-62. PMC: 2600263. DOI: 10.3201/eid1405.071312. View

19.

Specht C, Nong S, Dan J, Lee C, Levitz S . Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. J Infect Dis. 2007; 196(5):796-800. DOI: 10.1086/520536. View

20.

Singh S, Robbins N, Zaas A, Schell W, Perfect J, Cowen L . Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 2009; 5(7):e1000532. PMC: 2712069. DOI: 10.1371/journal.ppat.1000532. View